Fungal infections of the feet in patients with erysipelas of the lower limb: is it a significant clinical problem?

Korecka, Katarzyna; Mikiel, Dominik; Banaszak-Piechowska, Agnieszka; Neneman, Anna

doi:10.1007/s15010-021-01582-0

Cited by 5 publications

(5 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, obesity, venous insufficiency, and lymphedema were mentioned as recurrence risk factors. 15 A recent publication by Korecka et al 16 also found tinea pedis as an important risk factor for the disease, not only for the first episode, but also for recurrent erysipelas.…”

Section: Discussionmentioning

confidence: 95%

What factors affect the length of hospitalization in patients with erysipelas? A 10-year retrospective study of patients hospitalized in Lower Silesia, Poland

Łyko¹,

Kaczmarek²,

Nekrasova³

et al. 2021

Adv Clin Exp Med

View full text Add to dashboard Cite

Background.Erysipelas is an acute skin infection caused by group A and G streptococci. This infection is associated with many comorbidities and often requires hospitalization.Objectives. The aim of this study was to identify the factors related to the length of hospitalization in patients with erysipelas.Materials and methods. This retrospective study included 153 admissions of 135 patients (63 women and 72 men) hospitalized due to erysipelas from January 2010 to December 2019. Clinical symptoms, test results, comorbidities, and antibiotic treatments were taken into consideration as factors affecting the length of hospital stay.Results. The median length of hospitalization was 10 days (interquartile range (IQR) = 7-14). Women spent less time in the ward, but the difference was not significant. Features such as tinea pedis (15.5 days, IQR = 13.5-20; p = 0.002), anemia (11 days, IQR = 9-15; p = 0.02), chills (12 days, IQR = 9-15; p = 0.03), elevated serum C-reactive protein (CRP) level over 100 mg/L (11 days, IQR = 8-17; p = 0.02), and leukocytosis (11 days, IQR = 8-15, p = 0.005) were identified as prolonged hospitalization factors. Moreover, patients with erysipelas localized to the legs (p = 0.01) and with a gangrenous variant of erysipelas (p = 0.03) were hospitalized longer. The first-choice antibiotic was not significant in terms of prolonged hospitalization. Patients treated with clindamycin during hospitalization, regardless of whether it was a first-line or subsequent antibiotic, stayed in the ward significantly longer (p = 0.005). Conclusions.Patients suffering from erysipelas with the features identified above, have a higher risk of a prolonged stay in the hospital. Significantly increased inflammatory factors, anemia and tinea pedis contributed to prolonged hospitalization.

show abstract

Section: Discussionmentioning

confidence: 95%

What factors affect the length of hospitalization in patients with erysipelas? A 10-year retrospective study of patients hospitalized in Lower Silesia, Poland

Łyko¹,

Kaczmarek²,

Nekrasova³

et al. 2021

Adv Clin Exp Med

View full text Add to dashboard Cite

show abstract

“…Risk factors for erysipelas include microtraumas to the epidermis (e.g., effects of interdigital mycosis, abrasions, injuries), obesity, diabetes, immunosuppression, and alcoholism (6). Of particular note is the study by Korecka et al, which showed that foot mycosis is present in even 43% of patients with erysipelas (8).…”

Section: Discussionmentioning

confidence: 99%

“…efekt grzybicy międzypalcowej, przeczosów, urazów), otyłość, cukrzyca, immunosupresja i alkoholizm (6). Na szczególną uwagę zasługuje badanie Koreckiej i wsp., które wykazało, że grzybica stóp jest obecna nawet u 43% pacjentów z różą (8).…”

Section: Omówienieunclassified

Current challenges in diagnosing and treating infectious skin diseases – a case series

Jaworek,

Pełka,

Kozicka

et al. 2024

Przegl Epidemiol

View full text Add to dashboard Cite

Infectious skin diseases constitute a significant public health problem. Despite the systematic development of many modern diagnostic and therapeutic tools, they still pose a serious challenge for clinicians. Due to their prevalence and mild course in most cases, they are often marginalized, which can delay their diagnosis and treatment initiation. Such an approach in more clinically advanced cases can have serious consequences, sometimes leading to tragic outcomes. This work presents a series of four cases of common infectious skin diseases with an unusually atypical clinical picture: the history of a 49-year-old female patient with recurrent erysipelas of the right lower leg co-occurring with a SARS-CoV-2 infection, a 75-year-old male patient with a generalized form of herpes zoster, a 38-year-old female patient with a complicated severe course of head lice, and a 34-year-old male patient with a severe form of post-steroid mycosis. In each of these cases, difficulties in making the correct diagnosis were highlighted, even though they represent some of the most common bacterial, viral, parasitic, and fungal dermatoses. The paper discusses the risk factors for these diseases, the pathophysiology of their atypical course, the effects and challenges in the therapeutic approach conducted. Infectious skin dermatoses require aggressive treatment and should never be underestimated.

show abstract

“…Bacterial superinfection such as cellulitis (most common), pyoderma and lymphangitis may complicate tinea pedis as this may provide a portal of entry for bacteria, especially in patients with vesiculobullous tinea pedis and ulcerative tinea pedis. [96][97][98][99] The fungus can spread to other parts the destruction of the squamous cells. KOH dissolves the epithelial tissue, leaving behind easily visualized dichotomously branched, septate hyphae and spores.…”

Section: Complicationsmentioning

confidence: 99%

Tinea pedis: an updated review

Leung¹,

Barankin²,

Lam³

et al. 2023

DIC

View full text Add to dashboard Cite

Background Tinea pedis is one of the most common superficial fungal infections of the skin, with various clinical manifestations. This review aims to familiarize physicians with the clinical features, diagnosis and management of tinea pedis. Methods A search was conducted in April 2023 in PubMed Clinical Queries using the key terms ‘tinea pedis’ OR ‘athlete’s foot’. The search strategy included all clinical trials, observational studies and reviews published in English within the past 10 years. Results Tinea pedis is most often caused by Trichophyton rubrum and Trichophyton interdigitale . It is estimated that approximately 3% of the world population have tinea pedis. The prevalence is higher in adolescents and adults than in children. The peak age incidence is between 16 and 45 years of age. Tinea pedis is more common amongst males than females. Transmission amongst family members is the most common route, and transmission can also occur through indirect contact with contaminated belongings of the affected patient. Three main clinical forms of tinea pedis are recognized: interdigital, hyperkeratotic (moccasin-type) and vesiculobullous (inflammatory). The accuracy of clinical diagnosis of tinea pedis is low. A KOH wet-mount examination of skin scrapings of the active border of the lesion is recommended as a point-of-care testing. The diagnosis can be confirmed, if necessary, by fungal culture or culture-independent molecular tools of skin scrapings. Superficial or localized tinea pedis usually responds to topical antifungal therapy. Oral antifungal therapy should be reserved for severe disease, failed topical antifungal therapy, concomitant presence of onychomycosis or in immunocompromised patients. Conclusion Topical antifungal therapy (once to twice daily for 1–6 weeks) is the mainstay of treatment for superficial or localized tinea pedis. Examples of topical antifungal agents include allylamines (e.g. terbinafine), azoles (e.g. ketoconazole), benzylamine, ciclopirox, tolnaftate and amorolfine. Oral antifungal agents used for the treatment of tinea pedis include terbinafine, itraconazole and fluconazole. Combined therapy with topical and oral antifungals may increase the cure rate. The prognosis is good with appropriate antifungal treatment. Untreated, the lesions may persist and progress.

show abstract

Fungal infections of the feet in patients with erysipelas of the lower limb: is it a significant clinical problem?

Cited by 5 publications

References 26 publications

What factors affect the length of hospitalization in patients with erysipelas? A 10-year retrospective study of patients hospitalized in Lower Silesia, Poland

What factors affect the length of hospitalization in patients with erysipelas? A 10-year retrospective study of patients hospitalized in Lower Silesia, Poland

Current challenges in diagnosing and treating infectious skin diseases – a case series

Tinea pedis: an updated review

Contact Info

Product

Resources

About